血管紧张素-(1-7)/Mas受体轴通过调控NF-κB通路保护心肌细胞对抗高糖诱导的损伤

目的:探讨血管紧张素-(1-7)Ang-(1-7)]/Mas受体轴能否通过抑制核因子-κB(NF-κB)通路对抗高糖(HG)引起的心肌细胞损伤。方法:应用细胞计数检测试剂盒(CCK-8)检测心肌细胞存活率;双氯荧光素(DCFH-DA)染色荧光显微镜照相法检测胞内活性氧(ROS)水平;Hoechst 33258核染色荧光显微镜照相测定凋亡细胞的形态及数量的变化;JC-1染色法测定线粒体膜电位(MMP);应用免疫蛋白印迹法测定NF-κB p65和cleaved caspase-3蛋白的表达水平。结果:应用35 mmol/L葡萄糖分别处理H9c2心肌细胞30、60、90、120和150 min均能明显增加磷酸化(p)NF-κB p65的水平,其中60 min时,表达水平增加最明显;1μmol/L Ang-(1-7)与HG共同处理心肌细胞60 min能抑制HG对p-NF-κB p65表达的上调作用;0.1~30μmol/L的Ang-(1-7)与HG分别共处理心肌细胞24 h均能抑制HG的细胞毒性,使细胞存活率增多;另一方面,1μmol/L Ang-(1-7)能抑制HG引起的细胞凋亡、氧化应激、线粒体损伤等,使凋亡细胞数量、cleaved caspase-3表达、ROS生成水平及MMP丢失减少;但是10μmol/L Ang-(1-7)/Mas受体拮抗剂A-779能明显阻断上述的Ang-(1-7)的心肌细胞保护作用;与Ang-(1-7)的作用相似,100μmol/L PDTC(NF-κB抑制剂)与HG共处理心肌细胞24 h也能显著抑制上述的HG损伤作用。结论:Ang-(1-7)/Mas受体轴可通过抑制NF-κB通路对抗HG诱导的心肌细胞损伤。

Angiotensin-(1-7)/Mas receptor axis protects cardiomyocytes against high glucose-induced injury by modulating nuclear factor-κB pathway

AIM: To study whether the angiotensin-(1-7)Ang-(1-7)]/Mas receptor axis protects cardiomyocytes against high glucose(HG)-induced injury by inhibiting nuclear factor-κB(NF-κB) pathway. METHODS: The cell viability was measured by CCK-8 assay. The intracellular levels of reactive oxygen species(ROS) were detected by DCFH-DA staining. The number of apoptotic cells was tested by Hoechst 33258 nuclear staining. Mitochondrial membrane potential(MMP) was examined by JC-1 staining. The levels of NF-κB p65 subunit and cleaved caspase-3 protein were determined by Western blotting. RESULTS: Treatment of H9c2 cardiac cells with 35 mmol/L glucose(HG) for 30, 60, 90, 120 and 150 min significantly enhanced the levels of phosphorated(p) NF-κB p65, peaking at 60 min. Co-treatment of the cells with 1 μmol/L Ang-(1-7) and HG for 60 min attenuated the up-regulation of p-NF-κB p65 induced by HG. Co-treatment of the cells with Ang-(1-7) at concentrations of 0.1~30 μmol/L and HG for 24 h inhibited HG-induced cytotoxicity, evidenced by an increase in cell viability. On the other hand, 1 μmol/L Ang-(1-7) ameliorated HG-induced apoptosis, oxidative stress and mitochondrial damage, indicated by decreases in the number of apoptotic cells, cleaved caspase-3 level, ROS generation and MMP loss. However, the above cardioprotective effects of Ang-(1-7) were markedly blocked by A-779, an antagonist of Ang-(1-7) receptor(Mas receptor). Similarly, co-treatment of H9c2 cardiac cells with 100 μmol/L PDTC(an inhibitor of NF-κB) and HG for 24 h also obviously reduced the above injuries induced by HG. CONCLUSION: Ang-(1-7)/Mas receptor axis prevents the cardiomyocytes from the HG-induced injury by inhibiting NF-κB pathway.